In Europe, pharma restructuring has hit the U.K. hardest, industry experts say, with British drugmakers cutting 11 percent to 15 percent of its jobs across the board over the past two years--and the cuts aren't over yet. Report [1]
Links:
[1] http://www.pharmafocus.com/cda/focusH/1,2109,21-0-0-MAR_2009-focus_news_detail-0-492561,00.html